Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (GDRX) operates a leading digital healthcare platform that transforms prescription affordability through price transparency tools and pharmacy benefit solutions. This news hub provides investors and industry professionals with essential updates on financial performance, strategic initiatives, and regulatory developments impacting the company’s role in reshaping medication access.
Discover official press releases covering quarterly earnings, partnership announcements with healthcare stakeholders, and expansions of the company’s prescription savings ecosystem. Our curated collection includes analyses of market trends affecting GoodRx’s position in digital health, updates on telehealth integrations, and coverage of consumer affordability programs.
Key updates include developments in PBM collaborations, Medicare/Medicaid pricing initiatives, and technological advancements within the GoodRx platform. Bookmark this page to monitor how the company navigates evolving healthcare regulations while maintaining its mission to reduce out-of-pocket medication costs for millions of Americans.
GoodRx Holdings, Inc. (NASDAQ: GDRX) has appointed Scott Wagner, former CEO of GoDaddy, as its Interim CEO, effective April 25, 2023. Co-founders Doug Hirsch and Trevor Bezdek will transition to roles as Chief Mission Officer and Chairman, respectively. Wagner brings over 25 years of experience and aims to enhance product innovation and customer base growth. With his leadership, GoodRx aims to improve healthcare accessibility and affordability, having helped Americans save over $55 billion on medications. Hirsch will continue to focus on operationalizing the company's mission, while Bezdek will guide healthcare strategy and innovation. An update for investors is anticipated during the earnings call on May 10.
GoodRx Holdings, Inc. (GDRX) will release its Q1 2023 financial results before U.S. markets open on May 10, 2023. A conference call is scheduled for 5:00 a.m. Pacific Time to discuss the results and business outlook. GoodRx, a leading digital healthcare platform, provides consumers with access to lower prices for medications and telehealth consultations. Since its inception in 2011, GoodRx has helped individuals save over $55 billion on healthcare costs. The earnings call will be accessible online, and an archived version will be available for 30 days post-call.
FAQ
What is the current stock price of Goodrx Holdings (GDRX)?
What is the market cap of Goodrx Holdings (GDRX)?
